<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD Journal Publishing DTD v2.3 20070202//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName journalpublishing.dtd?><?SourceDTD.Version 2.3?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 2?><?release-delay 0|0 ?><front><journal-meta><journal-id journal-id-type="nlm-ta">J Biol Chem</journal-id><journal-id journal-id-type="hwp">jbc</journal-id><journal-id journal-id-type="pmc">jbc</journal-id><journal-id journal-id-type="publisher-id">JBC</journal-id><journal-title-group><journal-title>The Journal of Biological Chemistry</journal-title></journal-title-group><issn pub-type="ppub">0021-9258</issn><issn pub-type="epub">1083-351X</issn><publisher><publisher-name>American Society for Biochemistry and Molecular Biology</publisher-name><publisher-loc>9650 Rockville Pike, Bethesda, MD 20814, U.S.A.</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">2878558</article-id><article-id pub-id-type="publisher-id">M110.120972</article-id><article-id pub-id-type="doi">10.1074/jbc.M110.120972</article-id><article-categories><subj-group subj-group-type="heading"><subject>Neurobiology</subject></subj-group><subj-group><subject>Membrane Biology</subject></subj-group></article-categories><title-group><article-title>The Longin SNARE VAMP7/TI-VAMP Adopts a Closed Conformation<xref ref-type="fn" rid="FN1">*</xref><xref ref-type="fn" rid="FN2"><sup><inline-graphic xlink:href="sbox.jpg"/></sup></xref></article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Vivona</surname><given-names>Sandro</given-names></name><xref ref-type="aff" rid="aff1"><sup>&#8225;</sup></xref><xref ref-type="aff" rid="aff2"><sup>&#167;</sup></xref></contrib><contrib contrib-type="author"><name><surname>Liu</surname><given-names>Corey W.</given-names></name><xref ref-type="aff" rid="aff3"><sup>&#182;</sup></xref></contrib><contrib contrib-type="author"><name><surname>Strop</surname><given-names>Pavel</given-names></name><xref ref-type="aff" rid="aff1"><sup>&#8225;</sup></xref><xref ref-type="author-notes" rid="FN3"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Rossi</surname><given-names>Valeria</given-names></name><xref ref-type="aff" rid="aff2"><sup>&#167;</sup></xref></contrib><contrib contrib-type="author"><name><surname>Filippini</surname><given-names>Francesco</given-names></name><xref ref-type="aff" rid="aff2"><sup>&#167;</sup></xref></contrib><contrib contrib-type="author"><name><surname>Brunger</surname><given-names>Axel T.</given-names></name><xref ref-type="aff" rid="aff1"><sup>&#8225;</sup></xref><xref ref-type="aff" rid="aff4"><sup>&#8214;</sup></xref><xref ref-type="corresp" rid="cor1"><sup>2</sup></xref></contrib><aff id="aff1">From the <label>&#8225;</label>Departments of Molecular and Cellular Physiology, Neurology and Neurological Sciences, Structural Biology, and Photon Science, Stanford University, Stanford, California 94305, </aff><aff id="aff2">the <label>&#167;</label>Molecular Biology and Bioinformatics Unit (MOLBINFO), Department of Biology, University of Padua, viale G. Colombo, 3-35131 Padova, Italy, </aff><aff id="aff3">the <label>&#182;</label>Stanford Magnetic Resonance Laboratory, Stanford University School of Medicine, Stanford, California 94305, and </aff><aff id="aff4">the <label>&#8214;</label>Howard Hughes Medical Institute, Stanford, California 94305</aff></contrib-group><author-notes><corresp id="cor1"><label>2</label> To whom correspondence should be addressed. Tel.: <phone>650-736-1809</phone>; Fax: <fax>650-736-1961</fax>; E-mail: <email>brunger@stanford.edu</email>.</corresp><fn fn-type="present-address" id="FN3"><label>1</label><p>Present address: Rinat/Pfizer, Protein Engineering Dept., 230 E. Grant Ave., South San Francisco, CA 94080.</p></fn></author-notes><pub-date pub-type="ppub"><day>4</day><month>6</month><year>2010</year></pub-date><pub-date pub-type="epub"><day>8</day><month>4</month><year>2010</year></pub-date><pub-date pub-type="pmc-release"><day>8</day><month>4</month><year>2010</year></pub-date><!-- PMC Release delay is 0 months and 0 days and was based on the
							<pub-date pub-type="epub"/>. --><volume>285</volume><issue>23</issue><fpage>17965</fpage><lpage>17973</lpage><history><date date-type="received"><day>5</day><month>3</month><year>2010</year></date><date date-type="rev-recd"><day>7</day><month>4</month><year>2010</year></date></history><permissions><copyright-statement>&#169; 2010 by The American Society for Biochemistry and Molecular Biology, Inc.</copyright-statement><license license-type="open-access"><license-p><italic>Author's Choice</italic>&#8212;Final version full access.</license-p><license-p><ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/">Creative Commons Attribution Non-Commercial License</ext-link> applies to Author Choice Articles</license-p></license></permissions><self-uri xlink:title="pdf" xlink:type="simple" xlink:href="zbc02310017965.pdf"/><abstract><p>SNARE protein complexes are key mediators of exocytosis by juxtaposing opposing membranes, leading to membrane fusion. SNAREs generally consist of one or two core domains that can form a four-helix bundle with other SNARE core domains. Some SNAREs, such as syntaxin target-SNAREs and longin vesicular-SNAREs, have independent, folded N-terminal domains that can interact with their respective SNARE core domains and thereby affect the kinetics of SNARE complex formation. This autoinhibition mechanism is believed to regulate the role of the longin VAMP7/TI-VAMP in neuronal morphogenesis. Here we use nuclear magnetic resonance spectroscopy to study the longin-SNARE core domain interaction for VAMP7. Using complete backbone resonance assignments, chemical shift perturbations analysis, and hydrogen/deuterium exchange experiments, we conclusively show that VAMP7 adopts a preferentially closed conformation in solution. Taken together, the closed conformation of longins is conserved, in contrast to the syntaxin family of SNAREs for which mixtures of open and closed states have been observed. This may indicate different regulatory mechanisms for SNARE complexes containing syntaxins and longins, respectively.</p></abstract><kwd-group><kwd>Membrane Fusion</kwd><kwd>Neurodevelopment</kwd><kwd>NMR</kwd><kwd>Protein Conformation</kwd><kwd>Vesicles</kwd><kwd>Longin</kwd><kwd>Synaptobrevin</kwd><kwd>Syntaxin</kwd></kwd-group><funding-group><award-group><funding-source id="CS100">National Institutes of Health</funding-source><award-id rid="CS100">RO1-MH63105</award-id></award-group></funding-group></article-meta></front><body><sec sec-type="intro"><title>Introduction</title><p>The soluble <italic>N</italic>-ethylmaleimide-sensitive factor attachment protein receptor (SNARE)<xref ref-type="fn" rid="FN4"><sup>3</sup></xref> complex is the centerpiece of all intracellular membrane fusion reactions. SNARE proteins are localized in opposing membranes, and upon docking, form a <italic>trans</italic> four-helix bundle. Assembly of this complex promotes membrane juxtaposition and fusion (<xref ref-type="bibr" rid="B1">1</xref>, <xref ref-type="bibr" rid="B2">2</xref>). Each SNARE comprises of a characteristic SNARE core domain, a stretch of 60&#8211;70 amino acids defining all SNAREs as either Q-SNAREs or R-SNAREs (<xref ref-type="bibr" rid="B3">3</xref><xref ref-type="bibr" rid="B4 B5">&#8211;</xref><xref ref-type="bibr" rid="B6">6</xref>). SNARE complex formation is a highly controlled process, involving additional regulatory proteins and domains. A major role in modulating SNARE function is provided by N-terminal regulatory protein domains. In particular, the R-SNARE longins and the Q-SNARE syntaxins possess &#8764;120-amino acid-long N-terminal extensions called longin domain (LD) and Habc, respectively. LD and Habc can fold back on the SNARE core domain and regulate it by inhibiting interactions with other SNARE core domains. The existence of this interaction does not prevent SNARE complex formation, but it affects the kinetics of the assembly (<xref ref-type="bibr" rid="B7">7</xref>). For syntaxin, a major role of this interaction is to provide exocytosis with a conformational switch that in combination with SM (Munc18/nSec1) proteins (<xref ref-type="bibr" rid="B8">8</xref>, <xref ref-type="bibr" rid="B9">9</xref>) inhibits SNARE complex formation.</p><p>The energetics and kinetics of the syntaxin Habc-SNARE core domain interaction are not conserved despite the well conserved domain architecture of these molecules. Although neuronal Syntaxin 1A and yeast Sso1 have been observed in a closed conformation <italic>in vitro</italic> (<italic>i.e.</italic> with the N-terminal domain interacting with the SNARE core domain) (<xref ref-type="bibr" rid="B10">10</xref>, <xref ref-type="bibr" rid="B11">11</xref>), other syntaxins, such as the endosomal Tlg2p and Pep12p (<xref ref-type="bibr" rid="B12">12</xref>) or the yeast, vacuolar Vam3p, are predominantly open (<xref ref-type="bibr" rid="B13">13</xref>). Furthermore, varying results have been obtained for the kinetics of neuronal Syntaxin 1A. A single-molecule fluorescence correlation spectroscopy study revealed open-closed conformational transitions with a preference for the open conformation (<xref ref-type="bibr" rid="B14">14</xref>), whereas an NMR study suggested a dominant, although unstable, closed conformation (<xref ref-type="bibr" rid="B15">15</xref>). In longins, the transmembrane-anchoring region and the SNARE core domain are preceded by the N-terminal LD, a globular fold consisting of five antiparallel &#946;-strands sandwiched by two &#945;-helices on one side and one &#945;-helix on the other (&#946;1&#946;2&#945;1&#946;3&#946;4&#946;5&#945;2&#945;3 topology) (<xref ref-type="bibr" rid="B16">16</xref>, <xref ref-type="bibr" rid="B17">17</xref>). The conservation of this domain in all eukaryotes and in several traffic-related protein families other than the SNAREs raises interesting questions on its functional versatility (<xref ref-type="bibr" rid="B18">18</xref><xref ref-type="bibr" rid="B19 B20 B21">&#8211;</xref><xref ref-type="bibr" rid="B22">22</xref>). Longins comprise three subfamilies of v-SNAREs: Ykt6p, Sec22b, and VAMP7, also known as tetanus insensitive-VAMP (TI-VAMP). The LD targets these SNAREs to their specific traffic networks, where they function in both anterograde and retrograde vesicle fusion events (<xref ref-type="bibr" rid="B23">23</xref><xref ref-type="bibr" rid="B24">&#8211;</xref><xref ref-type="bibr" rid="B25">25</xref>).</p><p>Ykt6 is involved in trafficking to Golgi, the endosome, and the vacuole. It was the first longin for which a NMR study reported an LD-SNARE core intramolecular interaction, decreasing the rate of ternary SNARE complex formation (<xref ref-type="bibr" rid="B26">26</xref>). Farnesylation stabilizes this interaction and locks cytosolic Ykt6 in a closed conformation, whereas further lipidation (<italic>i.e.</italic> palmitoylation) anchors the protein to the vesicle membrane and is suggested to favor the open conformation (<xref ref-type="bibr" rid="B27">27</xref><xref ref-type="bibr" rid="B28 B29">&#8211;</xref><xref ref-type="bibr" rid="B30">30</xref>). Unlike Ykt6, VAMP7 and Sec22b are inserted in the membrane by a transmembrane domain, and it is unclear whether or not they adopt a closed conformation in their isolated form. A closed conformation has been suggested for Sec22b as a conformational epitope is induced in the LD &#945;2-&#945;3 interface by binding of the SNARE motif to &#945;1-&#946;3. However, in these experiments, Sec22b was in complex with Sec23/24 (<xref ref-type="bibr" rid="B24">24</xref>). A closed conformation can be hypothesized for VAMP7 as well because removal of the LD enhances SNARE complex formation both <italic>in vitro</italic> and <italic>in vivo</italic> (<xref ref-type="bibr" rid="B31">31</xref>). Endocytosis of VAMP7 is mediated by an interaction between its LD and a region of Hrb (<xref ref-type="bibr" rid="B25">25</xref>, <xref ref-type="bibr" rid="B32">32</xref>, <xref ref-type="bibr" rid="B33">33</xref>). The crystal structure (Protein Data Bank (PDB) ID <ext-link ext-link-type="pdb" xlink:href="2VX8">2VX8</ext-link>) of a recombinant chimera of VAMP7 LD fused with Hrb(136&#8211;176) shows that Hrb binds the LD and forms a closed conformation that is similar to that of Sec22b and Ykt6. Hrb competes with the VAMP7 SNARE core domain for binding to LD, suggesting a common binding mode also for the VAMP7 LD-SNARE core (<xref ref-type="bibr" rid="B32">32</xref>). In contrast to Ykt6, Sec22b, and VAMP7, a predominantly open conformation was found for the yeast-specific longin Nyv1p as no significant LD-SNARE core domain interaction was observed in NMR studies (<xref ref-type="bibr" rid="B34">34</xref>).</p><p>The biological role of the LD-SNARE core interaction of VAMP7 has been well established; it negatively regulates membrane fusion during neurite outgrowth in developing neurons and phagocytosis in macrophages, which require plasma membrane growth and remodeling, respectively (<xref ref-type="bibr" rid="B25">25</xref>, <xref ref-type="bibr" rid="B35">35</xref>, <xref ref-type="bibr" rid="B36">36</xref>). In contrast, the energetics and dynamics of this interaction are unknown. Here, we use NMR to conclusively show that the longin-SNARE VAMP7 adopts a predominantly closed conformation with remarkable stability. We then present a comparative perspective of the SNARE autoinhibition mechanism for longins and syntaxins.</p></sec><sec sec-type="methods"><title>EXPERIMENTAL PROCEDURES</title><sec><title/><sec><title/><sec><title>cDNAs for Bacterial Expression</title><p>All cDNAs used for bacterial expression were generated by standard PCR-based techniques from a cDNA encoding full-length human VAMP7 (a kind gift from Maurizio D'Esposito, Institute of Genetics and Biophysics-Consiglio Nazionale delle Ricerche (IGB-CNR), Naples, Italy) and subcloned into pET47b (Novagen) between XmaI and XhoI restriction sites.</p></sec><sec><title>Protein Expression and Purification</title><p>All recombinant proteins were expressed in BL21(DE3) cells (Invitrogen) for 4 h at 29 &#176;C after induction (<italic>A</italic><sub>600</sub> &#8764; 0.7) with 0.3 m<sc>m</sc> isopropyl-1-thio-&#946;-<sc>d</sc>-galactopyranoside at 37 &#176;C. Cells were lysed by sonication in 50 m<sc>m</sc> Tris-HCl (pH 7.5), 500 m<sc>m</sc> NaCl, 1 m<sc>m</sc> dithiothreitol (buffer A), 0.05% Triton X-100, 10 m<sc>m</sc> imidazole, and protease inhibitors. Crude lysates were centrifuged for 40 min at 48,400 &#215; <italic>g</italic>, and the supernatant was incubated with Ni<sup>2+</sup>-nitrilotriacetic acid-agarose beads (Qiagen) for 1 h at 4 &#176;C. The beads were washed with buffer A with 20 m<sc>m</sc> imidazole and eluted with buffer A and 300 m<sc>m</sc> imidazole. The His<sub>6</sub> tag was removed by PreScission protease (GE healthcare) for 60 h at 4 &#176;C. Further purification was achieved by gel filtration on a Superdex 75 column (GE Healthcare) in 20 m<sc>m</sc> potassium phosphate (pH 6.5), 100 m<sc>m</sc> NaCl, 1 m<sc>m</sc> dithiothreitol. Protein purity and integrity were monitored by SDS-PAGE and mass spectrometry.</p></sec><sec><title>Light Scattering</title><p>Size exclusion multiangle laser light scattering was performed using a Shodex KW-802.5 column at a flow rate of 0.5 ml/min. Measurements were performed in 20 m<sc>m</sc> Tris-HCl (pH 7.0), 150 m<sc>m</sc> NaCl, and 1 m<sc>m</sc> tris(2-carboxyethyl)phosphine. The elution profile was monitored by UV absorption at 280 nm, light scattering at 690 nm, and differential refractometry using Dawn and OptiLab instruments (Wyatt Technology). Analyses were carried out using the Astra software. For each sample, 100 &#956;l of protein at 3 mg/ml protein were loaded. The differential refractive index increment (dn/dc) value of 0.185 was used in all calculations.</p></sec><sec><title>Nuclear Magnetic Resonance Spectroscopy</title><p>Uniform <sup>15</sup>N and <sup>13</sup>C labeling in two combinations (only <sup>15</sup>N label or both <sup>15</sup>N and <sup>13</sup>C) was accomplished by growing <italic>Escherichia coli</italic> BL21(DE3) in M9 minimal media with <sup>15</sup>NH<sub>4</sub>Cl- and <sup>13</sup>C<sub>6</sub>-labeled glucose as the sole nitrogen and carbon sources, respectively. All samples were prepared in 20 m<sc>m</sc> potassium phosphate buffer (pH 6.5) containing 100 m<sc>m</sc> NaCl and 1 m<sc>m</sc> dithiothreitol, unless otherwise indicated, using a 90:10 (v/v) H<sub>2</sub>O:D<sub>2</sub>O mixture. Protein concentrations were assessed by UV spectrophotometry at 280 nm and the Bradford assay (Bio-Rad). For <sup>1</sup>H{<sup>15</sup>N}-HSQC experiments, we used: 18&#8211;450 &#956;<sc>m</sc> VAMP7(1&#8211;118), 300&#8211;500 &#956;<sc>m</sc> VAMP7(1&#8211;150), 60&#8211;320 &#956;<sc>m</sc> VAMP7(1&#8211;160), 11&#8211;210 &#956;<sc>m</sc> VAMP7(1&#8211;180)-L43S/Y45S, and 25&#8211;300 &#956;<sc>m</sc> VAMP7(1&#8211;180). VAMP7(1&#8211;118) was concentrated using Amicon Ultra-5K nominal molecular weight limit devices (Millipore) to 45, 90, and 150 &#956;<sc>m</sc> when incubated respectively with 100, 280, and 450 &#956;<sc>m</sc> non-labeled VAMP7(119&#8211;180). The hydrogen/deuterium exchange experiments were performed as follows. Samples of VAMP7(1&#8211;118), VAMP7(1&#8211;150), and VAMP7(1&#8211;180) in protonated NMR buffer were lyophilized. The samples, in turn, were dissolved in equivalent volumes of D<sub>2</sub>O (200 &#956;<sc>m</sc> final protein concentration), rapidly transferred to the spectrometer, and monitored by a series of fast <sup>1</sup>H{<sup>15</sup>N}-HSQC experiments. The protein concentrations were 450 &#956;<sc>m</sc> for all the <sup>1</sup>H-<sup>15</sup>N-<sup>13</sup>C three-dimensional experiments. These experiments were performed using standard sensitivity-enhanced, pulsed-field gradient-based pulse sequences for double and triple resonance spectra (<xref ref-type="bibr" rid="B37">37</xref>) and included: three-dimensional <sup>1</sup>H-<sup>15</sup>N NOESY-HSQC, HNCA, HN(CO)CA, HNCACB, CBCA(CO)NH, and C(CO)NH, all acquired on the uniformly <sup>15</sup>N, <sup>13</sup>C-labeled sample. All experiments were acquired on 600- or 800-MHz Varian <sup>UNITY</sup>INOVA spectrometers at 25 &#176;C, unless otherwise specified. Both instruments were equipped with 5-mm H{CN} triple resonance, gradient probes. All the data were acquired using the VNMR software (Varian, Inc.) and analyzed with SPARKY (<xref ref-type="bibr" rid="B38">38</xref>).</p></sec></sec></sec></sec><sec sec-type="results"><title>RESULTS</title><sec><title/><sec><title/><sec><title>Resonance Assignments and LD-SNARE Interaction Interface</title><p>To analyze the structural properties of the VAMP7 LD-SNARE core domain interaction, we acquired, assigned, and compared the <sup>1</sup>H{<sup>15</sup>N}-heteronuclear single-quantum coherence (HSQC) spectra of the isolated LD (VAMP7(1&#8211;118)) and of the entire cytoplasmic domain (1&#8211;180) of VAMP7. Both spectra showed good dispersion of N-H resonances, which is indicative of the heterogeneity of chemical environments characteristic for folded proteins (<xref ref-type="fig" rid="F1">Fig. 1</xref><italic>A</italic>). Many LD peaks show significant chemical shift perturbations in the presence of the SNARE core domain fragment. The change of chemical environment sensed by their nuclei is a direct evidence of the LD-SNARE interaction in VAMP7.</p><fig id="F1" position="float"><label>FIGURE 1.</label><caption><p><bold>LD-SNARE motif interaction in VAMP7.</bold> <italic>A</italic>, overlay of <sup>1</sup>H, <sup>15</sup>N-HSQC spectra of VAMP7(1&#8211;118) (<italic>gray</italic>) and VAMP7(1&#8211;180) (<italic>red</italic>). Only the assignments of the LD amide group of VAMP7(1&#8211;180) are shown (<italic>black labels</italic>). The <italic>color-coded bar diagram</italic> in the <italic>top left corner</italic> indicates the boundaries of the two constructs for which the spectra are shown with respect to the domain architecture of full-length VAMP7, residues 1&#8211;220: LD, SNARE core domain, and transmembrane domain (<italic>TM</italic>). <italic>B</italic>, summary of <sup>1</sup>H and <sup>15</sup>N combined chemical shift changes in the VAMP7 LD induced by the SNARE-motif. The combined <sup>1</sup>H and <sup>15</sup>N chemical shift changes are mapped on the schematic of the crystal structure of the VAMP7 LD bound to Hrb<sub>136&#8211;176</sub> (<italic>yellow</italic>) (PDB ID <ext-link ext-link-type="pdb" xlink:href="2VX8">2VX8</ext-link>) (<xref ref-type="bibr" rid="B32">32</xref>) using a <italic>gray/red</italic> color scale. They are defined as &#916;ppm = ((&#916;&#948;<sub>HN</sub>)<sup>2</sup> + (&#916;&#948;<sub>N</sub> &#215; &#945;<sub>N</sub>)<sup>2</sup>)&#189;, where &#916;&#948;<sub>HN</sub> and &#916;&#948;<sub>N</sub> are chemical shift differences of amide proton and nitrogen chemical shifts of the VAMP7 LD with and without the SNARE-motif. The scaling factor (&#945;<sub>N</sub>) used to normalize the <sup>1</sup>H and <sup>15</sup>N chemical shifts is 0.17.</p></caption><graphic xlink:href="zbc0281019780001"/></fig><p>To fully interpret the HSQC spectrum we performed full backbone assignments of both constructs. We obtained uniformly <sup>15</sup>N, <sup>13</sup>C-labeled VAMP7(1&#8211;118) and carried out HNCACB, CBCA(CO)NH, C(CO)NH, and three-dimensional <sup>1</sup>H-<sup>15</sup>N NOESY-HSQC triple resonance experiments. We unambiguously connected sequential C<sub>&#945;</sub>-C<sub>&#946;</sub> resonances through the comparison of the HNCACB and CBCA(CO)NH spectra in combination with the analysis of side chain carbon resonances in the C(CO)NH (<ext-link ext-link-type="uri" xlink:href="http://www.jbc.org/cgi/content/full/M110.120972/DC1">supplemental Fig. S1<italic>A</italic></ext-link>). The <sup>1</sup>H-<sup>15</sup>N NOESY-HSQC spectrum was used to review and confirm the assignment by verifying spatial proximity of N-H groups based on the structural information from the crystal structure of VAMP7 in complex with Hrb<sub>136&#8211;176</sub> (PDB ID <ext-link ext-link-type="pdb" xlink:href="2VX8">2VX8</ext-link>) (<xref ref-type="bibr" rid="B32">32</xref>). All visible backbone resonances in the VAMP7(1&#8211;118) <sup>1</sup>H{<sup>15</sup>N}-HSQC spectrum were assigned (<ext-link ext-link-type="uri" xlink:href="http://www.jbc.org/cgi/content/full/M110.120972/DC1">supplemental Fig. S2<italic>A</italic></ext-link>). Other than the 2 prolines (prolines do not include amides), only 7 residues of the LD were not detected. These residues are distributed in the &#945;2-&#945;3 loop and in the &#945;3-helix. The absence of strong signals for these residues may be due to conformational exchange likely combined with LD-LD self-association. In support of this notion, we observed LD dimerization by size exclusion chromatography multiangle laser light scattering and concentration-dependent perturbations in the LD <sup>1</sup>H{<sup>15</sup>N}-HSQC spectrum, which are consistent with the dimerization interface reported for Sec22b (<xref ref-type="bibr" rid="B24">24</xref>, <xref ref-type="bibr" rid="B39">39</xref>) (<ext-link ext-link-type="uri" xlink:href="http://www.jbc.org/cgi/content/full/M110.120972/DC1">supplemental Fig. S2</ext-link>). We then transferred all VAMP7(1&#8211;118) assignments to the <sup>1</sup>H{<sup>15</sup>N}-HSQC spectrum of a uniformly <sup>15</sup>N, <sup>13</sup>C-labeled VAMP7(1&#8211;180) and acquired HNCA, CA(CO)NH, CBCA(CO)NH, and C(CO)NH triple resonance experiments (<ext-link ext-link-type="uri" xlink:href="http://www.jbc.org/cgi/content/full/M110.120972/DC1">supplemental Fig. S1<italic>B</italic></ext-link>). VAMP7(1&#8211;180) is solely monomeric, as supported by size exclusion chromatography (data not shown) and the lack of change in the <sup>1</sup>H{<sup>15</sup>N}-HSQC spectra acquired in the concentration range from 25 to 750 &#956;<sc>m</sc>.</p><p>We mapped the LD chemical shift perturbations observed between VAMP7(1&#8211;118) and VAMP7(1&#8211;180) onto the VAMP7 LD-Hrb<sub>136&#8211;176</sub> crystal structure (PDB ID <ext-link ext-link-type="pdb" xlink:href="2VX8">2VX8</ext-link>) (<xref ref-type="fig" rid="F1">Fig. 1</xref><italic>B</italic>) (<xref ref-type="bibr" rid="B32">32</xref>). The largest perturbations for LD residues are found in the Hrb<sub>136&#8211;176</sub>-binding region. The most significant perturbations correspond to residues of the &#945;1-&#946;3 pocket, supporting a direct contact with the SNARE core domain with this pocket. Other chemical shift perturbations are observed in the &#946;5-&#945;2 loop and in the N-terminal half of &#945;2, likely as a combined result of spatial proximity to the N terminus of the SNARE core domain and to &#946;3-&#946;4 backbone adjustment due to the SNARE core domain interaction with the &#945;1-&#946;3 pocket. Similarly, a backbone adjustment induced on &#945;1 propagates through the central strand &#946;1 (residues Phe-5, Ala-6, Val-7) to the &#945;2-&#945;3 pocket. The interaction between LD and the SNARE core domain is also consistent with the reported LD-SNARE motif interactions for Ykt6 and Sec22b (<xref ref-type="bibr" rid="B24">24</xref>, <xref ref-type="bibr" rid="B26">26</xref>, <xref ref-type="bibr" rid="B27">27</xref>).</p></sec><sec><title>VAMP7 Adopts a Closed Conformation</title><p>The sharp lines obtained in the HSQC spectra of both the LD (VAMP7(1&#8211;118)) and the entire cytoplasmic domain (1&#8211;180) of VAMP7 indicate homogeneous chemical environments sensed by the amide protons of these proteins and thus unique conformations. Together with the observed chemical shift perturbations in the presence of SNARE core domain, this observation suggests a predominantly closed state for VAMP7(1&#8211;180). To validate this hypothesis, we performed hydrogen/deuterium exchange experiments to compare the protection from exchange with solvent deuterons in VAMP7(1&#8211;118), VAMP7(1&#8211;150), and VAMP7(1&#8211;180). When compared with VAMP7(1&#8211;118), VAMP7(1&#8211;150) showed modest extra protection of Lys-35, Ile-36, Cys-56, Gln-57, and Arg-59 in the &#945;1-&#946;3 pocket and of Phe-76 and Phe-78 in the stretch of &#945;2 likely facing the N-terminal portion of the SNARE core domain (data not shown). Remarkably, the VAMP7(1&#8211;180) construct exhibited a strong increase of protection for these residues as well as new protection for the &#945;1-&#946;3 residues Val-28, Gln-31, Ala-34, Ile-36, Leu-43, Thr-44, and Tyr-45 (<xref ref-type="fig" rid="F2">Fig. 2</xref>) with the latter being protected over 150 min at 25 &#176;C (data not shown). No other surfaces that were solvent-exposed in the isolated LD show any protection in VAMP7(1&#8211;180), supporting the notion that the C-terminal 20 residues of the SNARE core domain do not interact with the LD. To further validate that the LD-SNARE core domain interaction results in a stable, closed conformation, we mutated 2 key residues on the LD &#946;3 strand, <italic>i.e.</italic> VAMP7(1&#8211;180)-L43S/Y45S. Residues Leu-43 and Tyr-45 (corresponding to Leu-86 and Tyr-88 in chain A of the VAMP7 LD-Hrb<sub>136&#8211;176</sub> crystal structure) contribute the hydrophobic pocket on the surface of the LD that binds Hrb, and mutation of these residues into serines results in inhibition of the VAMP7-Hrb interaction (<xref ref-type="bibr" rid="B32">32</xref>). In agreement with the hypothesis that the SNARE core domain binds to the same surface region of the LD, residues Leu-43 and Tyr-45 have strong chemical shift changes (in <xref ref-type="fig" rid="F1">Fig. 1</xref><italic>B</italic>, they correspond to the <italic>red</italic>-labeled residues in the &#946;3), and they are protected against solvent in the presence of the SNARE core domain (<xref ref-type="fig" rid="F2">Fig. 2</xref><italic>B</italic>). The L43S/Y45S mutation results in a reduction of the LD resonance perturbations observed for wild-type VAMP7 (<xref ref-type="fig" rid="F3">Fig. 3</xref><italic>A</italic>), confirming the key role of these residues in the LD-SNARE core domain interaction.</p><fig id="F2" position="float"><label>FIGURE 2.</label><caption><p><bold>Deuterium solvent-exchange protection in VAMP7(1&#8211;118) and VAMP7(1&#8211;180).</bold> <italic>A</italic>, overlay of <sup>1</sup>H, <sup>15</sup>N-HSQC spectra of VAMP7(1&#8211;118) after 1 min and 25 s (<italic>green</italic>), 6 min and 15 s (<italic>orange</italic>), and 11 and 5 min and 5 s (<italic>red</italic>) from resuspension in deuterated solvent. <italic>Top left corner</italic>, the detectable resonance peaks of these three spectra are mapped on the schematic of the LD-Hrb<sub>136&#8211;176</sub> crystal structure (PDB ID <ext-link ext-link-type="pdb" xlink:href="2VX8">2VX8</ext-link>) (<xref ref-type="bibr" rid="B32">32</xref>) using the colors corresponding to the three spectra. The LD peaks that were not detected due to rapid deuterium exchange are colored <italic>gray. B</italic>, overlay of <sup>1</sup>H, <sup>15</sup>N-HSQC spectra of VAMP7(1&#8211;180) after 1 min and 20 s (<italic>green</italic>), 6 min and 5 s (<italic>orange</italic>), and 11 min (<italic>red</italic>) from resuspension in deuterated solvent. <italic>Top left corner</italic>, the detectable resonance peaks of these three spectra are colored in the LD-Hrb<sub>136&#8211;176</sub> as described for <italic>panel A</italic>.</p></caption><graphic xlink:href="zbc0281019780002"/></fig><fig id="F3" position="float"><label>FIGURE 3.</label><caption><p><bold>Stability of the VAMP7 closed conformation.</bold> <italic>A</italic>, effect of different <sup>15</sup>N-labeled recombinant constructs: VAMP7(1&#8211;118) (<italic>black</italic>), VAMP7(1&#8211;180)-L43S/Y45S (<italic>orange</italic>), and VAMP7(1&#8211;180) (<italic>cyan</italic>). The <italic>color-coded bar diagram</italic> in the <italic>top left corner</italic> indicates the boundaries of these three constructs for which the spectra are shown with respect to the domain architecture of full-length VAMP7, residues 1&#8211;220: LD, SNARE core domain, and transmembrane domain (<italic>TM</italic>). <italic>Black stars</italic> on the <italic>orange bar</italic> represent the L43S/Y45S point mutations. An overlay of the <sup>1</sup>H{<sup>15</sup>N}-HSQC spectra of these proteins is shown with matching colors for seven representative regions of the spectra. <italic>Black arrows</italic> indicate resonance perturbation trends from closed to open conformation. <italic>B</italic>, effect of ionic strength on <sup>15</sup>N-labeled VAMP7(1&#8211;180) in 100 m<sc>m</sc> NaCl (<italic>cyan</italic>), 250 m<sc>m</sc> NaCl (<italic>green</italic>), 400 m<sc>m</sc> NaCl (<italic>orange</italic>), 700 m<sc>m</sc> NaCl (<italic>red</italic>), and 1000 m<sc>m</sc> NaCl (<italic>purple</italic>) (legend in <italic>top left corner</italic>). <italic>Two red arrows</italic> on the ribbon diagram point to the position of residues Gly-22 and Tyr-45 in the LD (<italic>gray</italic>) as found in the crystal structure of VAMP7 LD in complex with the Hrb<sub>136&#8211;176</sub> fragment of the protein (<italic>yellow</italic>) (PDB ID <ext-link ext-link-type="pdb" xlink:href="2VX8">2VX8</ext-link>) (<xref ref-type="bibr" rid="B32">32</xref>). The <sup>1</sup>H{<sup>15</sup>N}-HSQC resonances for these 2 residues at the five saline conditions are superimposed and shown on the <italic>right</italic> with colors matching the legend. <italic>C</italic>, effect of temperature on <sup>15</sup>N-labeled VAMP7(1&#8211;180). Spectra were acquired at 25 &#176;C (<italic>cyan</italic>), 37 &#176;C (purple), 42 &#176;C (<italic>red</italic>), and 50 &#176;C (<italic>orange</italic>) (legend in <italic>top left corner</italic>). An overlay of the <sup>1</sup>H{<sup>15</sup>N}-HSQC spectra of VAMP7(1&#8211;180) at these temperatures is shown with the same spectral regions of <italic>panel A</italic> to illustrate the opposite shift perturbation trend (from closed toward open state) indicated by the <italic>black arrows</italic>.</p></caption><graphic xlink:href="zbc0281019780003"/></fig><p>To determine the minimal LD-binding site, we designed two truncations, VAMP7(1&#8211;160) and VAMP7(1&#8211;150), corresponding to the same length of the LD-binding sites found in the crystal structures of VAMP7-Hrb and Sec22b (<xref ref-type="bibr" rid="B24">24</xref>, <xref ref-type="bibr" rid="B32">32</xref>). We also tested the contribution of the covalent linker between LD and SNARE core domain by acquiring the <sup>1</sup>H{<sup>15</sup>N}-HSQC spectrum of <sup>15</sup>N-labeled LD with an excess of non-labeled SNARE core domain. With the exception of the VAMP7(1&#8211;160) construct, whose HSQC spectrum is essentially that of VAMP7(1&#8211;180), these constructs result in smaller chemical shift perturbations and peak broadening when compared with VAMP7(1&#8211;180) (<xref ref-type="fig" rid="F4">Fig. 4</xref>), supporting fast exchange between open and closed states. Our data show that the native, full-length cytoplasmic domain of VAMP7 adopts a predominantly closed conformation that requires at least the N-terminal 160 residues of VAMP7 to be detectable and that VAMP7 is fully stabilized in the closed state by the C-terminal 20 residues preceding the transmembrane domain.</p><fig id="F4" position="float"><label>FIGURE 4.</label><caption><p><bold>Effect of sequence specificity, construct length, and covalent linkage on the LD-SNARE core interaction.</bold> The effect of truncation and mutation of <sup>15</sup>N-labeled VAMP7 constructs on LD resonances is shown as follows: VAMP7(1&#8211;118) (<italic>black</italic>), VAMP7(1&#8211;150) (<italic>yellow</italic>), VAMP7(1&#8211;160) (<italic>purple</italic>), VAMP7(1&#8211;180)-L43S/Y45S (<italic>orange</italic>), VAMP7(1&#8211;180) (<italic>cyan</italic>), and VAMP7(1&#8211;118) (<italic>green</italic>) incubated with non-labeled VAMP7(119&#8211;180) (<italic>dashed gray line</italic>). The <italic>color-coded bar diagram</italic> in the <italic>top left corner</italic> indicates the boundaries of these six constructs for which the spectra are shown with respect to the domain architecture of full-length VAMP7, residues 1&#8211;220: LD, SNARE core domain, and transmembrane domain (<italic>TM</italic>). <italic>Black stars</italic> on the <italic>orange bar</italic> represent the L43S/Y45S mutation from the canonical amino acid sequence of VAMP7. An overlay of the <sup>1</sup>H{<sup>15</sup>N}-HSQC spectra of these proteins is shown with matching colors in seven representative regions of the spectra (same regions shown in <xref ref-type="fig" rid="F3">Fig. 3</xref>, <italic>A</italic> and <italic>C</italic>). The three panels on the <italic>left</italic> are shown with lower contour levels to display broadened resonances. <italic>Black arrows</italic> indicate the chemical shift perturbation trends from the closed to the open conformation.</p></caption><graphic xlink:href="zbc0281019780004"/></fig><p>VAMP7 adopts a stable, closed conformation without any known auxiliary proteins required to stabilize it. By contrast, a modest increase in ionic strength (150 m<sc>m</sc> NaCl) is sufficient to destabilize the closed conformation of Syntaxin 1A in the absence of Munc18 (<xref ref-type="bibr" rid="B15">15</xref>). Hence, we investigated the stability of the closed conformation of VAMP7 with respect to the ionic strength to compare these two systems. We titrated VAMP7(1&#8211;180) in 100, 250, 400, 700, and 1000 m<sc>m</sc> NaCl and recorded a <sup>1</sup>H{<sup>15</sup>N}-HSQC spectrum for each condition. Intriguingly, none of these conditions achieved an opening of the closed conformation (<xref ref-type="fig" rid="F3">Fig. 3</xref><italic>B</italic>). Such resistance to ionic strength is likely due to the hydrophobic character of the &#945;1-&#946;3 pocket, in particular, residues Phe-25, Val-28, Ile-32, Leu-43, Tyr-45, and Phe-52.</p><p>We further investigated the stability of the closed conformation of VAMP7 by monitoring the effect of increasing temperature (25, 37, 42, and 50 &#176;C) on the <sup>1</sup>H{<sup>15</sup>N}-HSQC spectrum of VAMP7(1&#8211;180) (<xref ref-type="fig" rid="F3">Fig. 3</xref><italic>C</italic>). The increase of temperature causes a progressive although incomplete shift of the LD resonances toward their respective &#8220;open state&#8221; values (<italic>i.e.</italic> isolated LD), with the 37, 42, and 50 &#176;C spectra representing a predominantly closed, an intermediate, and a predominantly open conformation, respectively. In analogy with the increase of ionic strength, the temperature effect is larger for Gly-22 than for other residues such as Tyr-45, which still shows interaction with the SNARE core domain at 50 &#176;C. Taken together, VAMP7 adopts a stable, closed conformation in solution even in the absence of any known accessory proteins.</p><p>We observed spontaneous SNARE complex assembly during incubation of either VAMP7(1&#8211;160) or VAMP7(1&#8211;180) with SNAP25 and Syntaxin 1A <italic>in vitro</italic> (data not shown), consistent with a previous report (<xref ref-type="bibr" rid="B31">31</xref>). Our hydrogen/deuterium exchange experiments show poor protection for LD-&#945;1 residues Val-28 and Gln-31 (<xref ref-type="fig" rid="F2">Fig. 2</xref><italic>B</italic>, <italic>green residues</italic> in the ribbon diagram) and no protection for Phe-25 and Gly-22, located in the N-terminal portion of &#945;1 and the &#946;2-&#945;1 loop, respectively. This is consistent with higher sensitivity of Gly-22 to salt and temperature increases (<xref ref-type="fig" rid="F3">Fig. 3</xref>, <italic>B</italic> and <italic>C</italic>). We speculate that the C-terminal LD-binding site would therefore be available for initiating SNARE complex assembly. Once interactions with the other SNAREs have been initiated, the remainder of the VAMP7 SNARE core domain will then participate in the complex assembly as a result of local conformational fluctuations.</p></sec></sec></sec></sec><sec sec-type="discussion"><title>DISCUSSION</title><p>The longin v-SNAREs Ykt6, VAMP7, and Sec22b are characterized by an autoinhibitory intramolecular interaction between the LD and the SNARE core domain. In Ykt6, lipidation contributes to regulate this interaction by stabilizing a cytosolic closed conformation and likely allowing opening transitions upon anchoring to the membrane (<xref ref-type="bibr" rid="B27">27</xref>, <xref ref-type="bibr" rid="B29">29</xref>, <xref ref-type="bibr" rid="B30">30</xref>). Instead, Sec22b and VAMP7 are permanently inserted in the membrane through a transmembrane region (<xref ref-type="bibr" rid="B24">24</xref>, <xref ref-type="bibr" rid="B30">30</xref>, <xref ref-type="bibr" rid="B32">32</xref>, <xref ref-type="bibr" rid="B39">39</xref>).</p><p>In this study, we conclusively show that VAMP7 adopts a stable, closed conformation in solution. We also show how its stability depends on the full extent of the SNARE core domain, although not all residues of the SNARE core domain contribute equally to the interaction. Although lipidation provides cytosolic Ykt6 with a larger interaction surface between the LD and the SNARE core, we show here that a stable, dominantly closed conformation is also possible for transmembrane longin v-SNAREs in the absence of lipidation; unlike what was shown for Ykt6 (<xref ref-type="bibr" rid="B30">30</xref>), we do not observe dodecylphosphocholine binding to VAMP7 (data not shown). This observation is consistent with the hypothesis that cytosolic longin v-SNAREs require a stricter autoinhibition than membrane-bound ones to prevent unspecific SNARE core pairing (<xref ref-type="bibr" rid="B30">30</xref>). Available data are consistent with the conservation of a closed conformation of longins (with the exception of the <italic>Saccharomyces</italic>-specific Nyv1p) (<xref ref-type="bibr" rid="B34">34</xref>). Together with previous studies of syntaxins, we can compare the two different autoinhibitory SNAREs. Despite the conceptual analogy of open and closed states, these two SNAREs differ in terms of conservation and stability of the closed conformation. In contrast with longins, the existence of a closed conformation in solution is not conserved in syntaxins (<xref ref-type="bibr" rid="B10">10</xref><xref ref-type="bibr" rid="B11 B12">&#8211;</xref><xref ref-type="bibr" rid="B13">13</xref>). Additionally, in a subset of syntaxins that adopt a closed conformation, the closed conformation is only marginally stable and can be easily disrupted, <italic>e.g.</italic> by favoring intermolecular SNARE core pairing at higher ionic strength (<xref ref-type="bibr" rid="B15">15</xref>). The sensitivity to solution conditions and the intrinsic flexibility of the syntaxin C terminus likely explain the differences in energetics and kinetics between open and closed states obtained in previous fluorescence correlation spectroscopy and NMR studies (<xref ref-type="bibr" rid="B14">14</xref>, <xref ref-type="bibr" rid="B15">15</xref>). Syntaxins require accessory SM proteins to be held in an &#8220;arrested&#8221; closed state that inhibits SNARE complex formation.</p><p><italic>In vitro</italic>, VAMP7 can form SNARE complex with the specific target-SNAREs. The higher stability of the closed state for VAMP7 when compared with syntaxins poses the question of whether longins require accessory proteins to further stabilize an arrested state to inhibit SNARE complex formation <italic>in vivo</italic> or whether the LD is sufficient to provide a similar inhibiting role to syntaxins, even without additional SM proteins. Although the interaction between LD and SNARE core might be sufficient to modulate SNARE complex assembly, we cannot exclude that an unknown protein factor destabilizes this interaction to achieve the timely SNARE complex assembly <italic>in vivo</italic> as suggested (<xref ref-type="bibr" rid="B35">35</xref>). It is also possible that SNARE assembly regulation is entirely different for SNARE complexes involving VAMP7. Our results have provided the molecular foundation to address these questions in future experiments.</p></sec>
      <sec sec-type="supplementary-material">
         <title>Supplementary Material</title>
         <supplementary-material id="PMC_1" content-type="local-data">
            <caption>
               <title>Supplemental Data</title>
            </caption>
            <media mimetype="text" mime-subtype="html" xlink:href="supp_285_23_17965__index.html"/>
            <media xlink:role="associated-file" mimetype="application" mime-subtype="pdf" xlink:href="supp_M110.120972_jbc.M110.120972-1.pdf"/>
         </supplementary-material>
      </sec>
   </body><back><fn-group><fn fn-type="supported-by" id="FN1"><label>*</label><p>This work was supported, in whole or in part, by National Institutes of Health Grant RO1-MH63105 (to A. T. B.). This work was also supported by grants from the MIUR-PRIN2005 and the Padua University (PRAT2007 Project CPDA077345/07) (to F. F.).</p></fn><fn fn-type="other"><p>The HSQC spectra of VAMP7(1&#8211;118) and VAMP7(1&#8211;180) have been deposited in the Biological Magnetic Resonance Data Bank (BMRB) with accession numbers <ext-link ext-link-type="gen" xlink:href="16866">16866</ext-link> and <ext-link ext-link-type="gen" xlink:href="16867">16867</ext-link>, respectively.</p></fn><fn fn-type="supplementary-material" id="FN2"><label><inline-graphic xlink:href="sbox.jpg"/></label><p>The on-line version of this article (available at <ext-link ext-link-type="uri" xlink:href="http://www.jbc.org">http://www.jbc.org</ext-link>) contains <ext-link ext-link-type="uri" xlink:href="http://www.jbc.org/cgi/content/full/M110.120972/DC1">supplemental Figs. S1 and S2</ext-link>.</p></fn></fn-group><fn-group content-type="abbreviations"><fn id="FN4"><label>3</label><p>The abbreviations used are:
<def-list><def-item><term id="G1">SNARE</term><def><p>soluble <italic>N</italic>-ethylmaleimide-sensitive factor attachment protein receptor</p></def></def-item><def-item><term id="G2">v-SNARE</term><def><p>vesicular-SNARE</p></def></def-item><def-item><term id="G3">VAMP</term><def><p>vesicle-associated membrane protein</p></def></def-item><def-item><term id="G4">LD</term><def><p>longin domain</p></def></def-item><def-item><term id="G5">HSQC</term><def><p>heteronuclear single quantum correlation</p></def></def-item><def-item><term id="G6">NOESY</term><def><p>nuclear Overhauser effect spectroscopy.</p></def></def-item></def-list></p></fn></fn-group><ack><title>Acknowledgment</title><p>We thank Thierry Galli for critical reading.</p></ack><ref-list><title>REFERENCES</title><ref id="B1"><label>1.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sutton</surname><given-names>R. B.</given-names></name><name><surname>Fasshauer</surname><given-names>D.</given-names></name><name><surname>Jahn</surname><given-names>R.</given-names></name><name><surname>Brunger</surname><given-names>A. T.</given-names></name></person-group> (<year>1998</year>) <source>Nature</source><volume>395</volume>, <fpage>347</fpage>&#8211;<lpage>353</lpage><pub-id pub-id-type="pmid">9759724</pub-id></mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>W.</given-names></name><name><surname>Parpura</surname><given-names>V.</given-names></name></person-group> (<year>2009</year>) <source>Front. Neuroenergetics</source><volume>1</volume>, <fpage>5</fpage><pub-id pub-id-type="pmid">19597565</pub-id></mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fasshauer</surname><given-names>D.</given-names></name><name><surname>Sutton</surname><given-names>R. B.</given-names></name><name><surname>Brunger</surname><given-names>A. T.</given-names></name><name><surname>Jahn</surname><given-names>R.</given-names></name></person-group> (<year>1998</year>) <source>Proc. Natl. Acad. Sci. U.S.A.</source><volume>95</volume>, <fpage>15781</fpage>&#8211;<lpage>15786</lpage><pub-id pub-id-type="pmid">9861047</pub-id></mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brunger</surname><given-names>A. T.</given-names></name></person-group> (<year>2005</year>) <source>Q. Rev. Biophys.</source><volume>38</volume>, <fpage>1</fpage>&#8211;<lpage>47</lpage><pub-id pub-id-type="pmid">16336742</pub-id></mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jahn</surname><given-names>R.</given-names></name><name><surname>Scheller</surname><given-names>R. H.</given-names></name></person-group> (<year>2006</year>) <source>Nat. Rev. Mol. Cell Biol.</source><volume>7</volume>, <fpage>631</fpage>&#8211;<lpage>643</lpage><pub-id pub-id-type="pmid">16912714</pub-id></mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wickner</surname><given-names>W.</given-names></name><name><surname>Schekman</surname><given-names>R.</given-names></name></person-group> (<year>2008</year>) <source>Nat. Struct. Mol. Biol.</source><volume>15</volume>, <fpage>658</fpage>&#8211;<lpage>664</lpage><pub-id pub-id-type="pmid">18618939</pub-id></mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fasshauer</surname><given-names>D.</given-names></name><name><surname>Antonin</surname><given-names>W.</given-names></name><name><surname>Subramaniam</surname><given-names>V.</given-names></name><name><surname>Jahn</surname><given-names>R.</given-names></name></person-group> (<year>2002</year>) <source>Nat. Struct. Biol.</source><volume>9</volume>, <fpage>144</fpage>&#8211;<lpage>151</lpage><pub-id pub-id-type="pmid">11786917</pub-id></mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Burkhardt</surname><given-names>P.</given-names></name><name><surname>Hattendorf</surname><given-names>D. A.</given-names></name><name><surname>Weis</surname><given-names>W. I.</given-names></name><name><surname>Fasshauer</surname><given-names>D.</given-names></name></person-group> (<year>2008</year>) <source>EMBO J.</source><volume>27</volume>, <fpage>923</fpage>&#8211;<lpage>933</lpage><pub-id pub-id-type="pmid">18337752</pub-id></mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gerber</surname><given-names>S. H.</given-names></name><name><surname>Rah</surname><given-names>J. C.</given-names></name><name><surname>Min</surname><given-names>S. W.</given-names></name><name><surname>Liu</surname><given-names>X.</given-names></name><name><surname>de Wit</surname><given-names>H.</given-names></name><name><surname>Dulubova</surname><given-names>I.</given-names></name><name><surname>Meyer</surname><given-names>A. C.</given-names></name><name><surname>Rizo</surname><given-names>J.</given-names></name><name><surname>Arancillo</surname><given-names>M.</given-names></name><name><surname>Hammer</surname><given-names>R. E.</given-names></name><name><surname>Verhage</surname><given-names>M.</given-names></name><name><surname>Rosenmund</surname><given-names>C.</given-names></name><name><surname>S&#252;dhof</surname><given-names>T. C.</given-names></name></person-group> (<year>2008</year>) <source>Science</source><volume>321</volume>, <fpage>1507</fpage>&#8211;<lpage>1510</lpage><pub-id pub-id-type="pmid">18703708</pub-id></mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nicholson</surname><given-names>K. L.</given-names></name><name><surname>Munson</surname><given-names>M.</given-names></name><name><surname>Miller</surname><given-names>R. B.</given-names></name><name><surname>Filip</surname><given-names>T. J.</given-names></name><name><surname>Fairman</surname><given-names>R.</given-names></name><name><surname>Hughson</surname><given-names>F. M.</given-names></name></person-group> (<year>1998</year>) <source>Nat. Struct. Biol.</source><volume>5</volume>, <fpage>793</fpage>&#8211;<lpage>802</lpage><pub-id pub-id-type="pmid">9731774</pub-id></mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fiebig</surname><given-names>K. M.</given-names></name><name><surname>Rice</surname><given-names>L. M.</given-names></name><name><surname>Pollock</surname><given-names>E.</given-names></name><name><surname>Brunger</surname><given-names>A. T.</given-names></name></person-group> (<year>1999</year>) <source>Nat. Struct. Biol.</source><volume>6</volume>, <fpage>117</fpage>&#8211;<lpage>123</lpage><pub-id pub-id-type="pmid">10048921</pub-id></mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dulubova</surname><given-names>I.</given-names></name><name><surname>Yamaguchi</surname><given-names>T.</given-names></name><name><surname>Gao</surname><given-names>Y.</given-names></name><name><surname>Min</surname><given-names>S. W.</given-names></name><name><surname>Huryeva</surname><given-names>I.</given-names></name><name><surname>S&#252;dhof</surname><given-names>T. C.</given-names></name><name><surname>Rizo</surname><given-names>J.</given-names></name></person-group> (<year>2002</year>) <source>EMBO J.</source><volume>21</volume>, <fpage>3620</fpage>&#8211;<lpage>3631</lpage><pub-id pub-id-type="pmid">12110575</pub-id></mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dulubova</surname><given-names>I.</given-names></name><name><surname>Yamaguchi</surname><given-names>T.</given-names></name><name><surname>Wang</surname><given-names>Y.</given-names></name><name><surname>S&#252;dhof</surname><given-names>T. C.</given-names></name><name><surname>Rizo</surname><given-names>J.</given-names></name></person-group> (<year>2001</year>) <source>Nat. Struct. Biol.</source><volume>8</volume>, <fpage>258</fpage>&#8211;<lpage>264</lpage><pub-id pub-id-type="pmid">11224573</pub-id></mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Margittai</surname><given-names>M.</given-names></name><name><surname>Widengren</surname><given-names>J.</given-names></name><name><surname>Schweinberger</surname><given-names>E.</given-names></name><name><surname>Schr&#246;der</surname><given-names>G. F.</given-names></name><name><surname>Felekyan</surname><given-names>S.</given-names></name><name><surname>Haustein</surname><given-names>E.</given-names></name><name><surname>K&#246;nig</surname><given-names>M.</given-names></name><name><surname>Fasshauer</surname><given-names>D.</given-names></name><name><surname>Grubm&#252;ller</surname><given-names>H.</given-names></name><name><surname>Jahn</surname><given-names>R.</given-names></name><name><surname>Seidel</surname><given-names>C. A.</given-names></name></person-group> (<year>2003</year>) <source>Proc. Natl. Acad. Sci. U.S.A.</source><volume>100</volume>, <fpage>15516</fpage>&#8211;<lpage>15521</lpage><pub-id pub-id-type="pmid">14668446</pub-id></mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>X.</given-names></name><name><surname>Lu</surname><given-names>J.</given-names></name><name><surname>Dulubova</surname><given-names>I.</given-names></name><name><surname>Rizo</surname><given-names>J.</given-names></name></person-group> (<year>2008</year>) <source>J. Biomol. NMR</source><volume>41</volume>, <fpage>43</fpage>&#8211;<lpage>54</lpage><pub-id pub-id-type="pmid">18458823</pub-id></mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Filippini</surname><given-names>F.</given-names></name><name><surname>Rossi</surname><given-names>V.</given-names></name><name><surname>Galli</surname><given-names>T.</given-names></name><name><surname>Budillon</surname><given-names>A.</given-names></name><name><surname>D'Urso</surname><given-names>M.</given-names></name><name><surname>D'Esposito</surname><given-names>M.</given-names></name></person-group> (<year>2001</year>) <source>Trends Biochem. Sci</source><volume>26</volume>, <fpage>407</fpage>&#8211;<lpage>409</lpage><pub-id pub-id-type="pmid">11440841</pub-id></mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rossi</surname><given-names>V.</given-names></name><name><surname>Banfield</surname><given-names>D. K.</given-names></name><name><surname>Vacca</surname><given-names>M.</given-names></name><name><surname>Dietrich</surname><given-names>L. E.</given-names></name><name><surname>Ungermann</surname><given-names>C.</given-names></name><name><surname>D'Esposito</surname><given-names>M.</given-names></name><name><surname>Galli</surname><given-names>T.</given-names></name><name><surname>Filippini</surname><given-names>F.</given-names></name></person-group> (<year>2004</year>) <source>Trends Biochem. Sci</source><volume>29</volume>, <fpage>682</fpage>&#8211;<lpage>688</lpage><pub-id pub-id-type="pmid">15544955</pub-id></mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Collins</surname><given-names>B. M.</given-names></name><name><surname>McCoy</surname><given-names>A. J.</given-names></name><name><surname>Kent</surname><given-names>H. M.</given-names></name><name><surname>Evans</surname><given-names>P. R.</given-names></name><name><surname>Owen</surname><given-names>D. J.</given-names></name></person-group> (<year>2002</year>) <source>Cell</source><volume>109</volume>, <fpage>523</fpage>&#8211;<lpage>535</lpage><pub-id pub-id-type="pmid">12086608</pub-id></mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kinch</surname><given-names>L. N.</given-names></name><name><surname>Grishin</surname><given-names>N. V.</given-names></name></person-group> (<year>2006</year>) <source>Protein Sci.</source><volume>15</volume>, <fpage>2669</fpage>&#8211;<lpage>2674</lpage><pub-id pub-id-type="pmid">17075139</pub-id></mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schlenker</surname><given-names>O.</given-names></name><name><surname>Hendricks</surname><given-names>A.</given-names></name><name><surname>Sinning</surname><given-names>I.</given-names></name><name><surname>Wild</surname><given-names>K.</given-names></name></person-group> (<year>2006</year>) <source>J. Biol. Chem.</source><volume>281</volume>, <fpage>8898</fpage>&#8211;<lpage>8906</lpage><pub-id pub-id-type="pmid">16439358</pub-id></mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>Y. G.</given-names></name><name><surname>Raunser</surname><given-names>S.</given-names></name><name><surname>Munger</surname><given-names>C.</given-names></name><name><surname>Wagner</surname><given-names>J.</given-names></name><name><surname>Song</surname><given-names>Y. L.</given-names></name><name><surname>Cygler</surname><given-names>M.</given-names></name><name><surname>Walz</surname><given-names>T.</given-names></name><name><surname>Oh</surname><given-names>B. H.</given-names></name><name><surname>Sacher</surname><given-names>M.</given-names></name></person-group> (<year>2006</year>) <source>Cell</source><volume>127</volume>, <fpage>817</fpage>&#8211;<lpage>830</lpage><pub-id pub-id-type="pmid">17110339</pub-id></mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vedovato</surname><given-names>M.</given-names></name><name><surname>Rossi</surname><given-names>V.</given-names></name><name><surname>Dacks</surname><given-names>J. B.</given-names></name><name><surname>Filippini</surname><given-names>F.</given-names></name></person-group> (<year>2009</year>) <source>BMC Genomics</source><volume>10</volume>, <fpage>510</fpage><pub-id pub-id-type="pmid">19889231</pub-id></mixed-citation></ref><ref id="B23"><label>23.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meiringer</surname><given-names>C. T.</given-names></name><name><surname>Auffarth</surname><given-names>K.</given-names></name><name><surname>Hou</surname><given-names>H.</given-names></name><name><surname>Ungermann</surname><given-names>C.</given-names></name></person-group> (<year>2008</year>) <source>Traffic</source><volume>9</volume>, <fpage>1510</fpage>&#8211;<lpage>1521</lpage><pub-id pub-id-type="pmid">18541004</pub-id></mixed-citation></ref><ref id="B24"><label>24.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mancias</surname><given-names>J. D.</given-names></name><name><surname>Goldberg</surname><given-names>J.</given-names></name></person-group> (<year>2007</year>) <source>Mol. Cell</source><volume>26</volume>, <fpage>403</fpage>&#8211;<lpage>414</lpage><pub-id pub-id-type="pmid">17499046</pub-id></mixed-citation></ref><ref id="B25"><label>25.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chaineau</surname><given-names>M.</given-names></name><name><surname>Danglot</surname><given-names>L.</given-names></name><name><surname>Galli</surname><given-names>T.</given-names></name></person-group> (<year>2009</year>) <source>FEBS Lett.</source><volume>583</volume>, <fpage>3817</fpage>&#8211;<lpage>3826</lpage><pub-id pub-id-type="pmid">19837067</pub-id></mixed-citation></ref><ref id="B26"><label>26.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tochio</surname><given-names>H.</given-names></name><name><surname>Tsui</surname><given-names>M. M.</given-names></name><name><surname>Banfield</surname><given-names>D. K.</given-names></name><name><surname>Zhang</surname><given-names>M.</given-names></name></person-group> (<year>2001</year>) <source>Science</source><volume>293</volume>, <fpage>698</fpage>&#8211;<lpage>702</lpage><pub-id pub-id-type="pmid">11474112</pub-id></mixed-citation></ref><ref id="B27"><label>27.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hasegawa</surname><given-names>H.</given-names></name><name><surname>Yang</surname><given-names>Z.</given-names></name><name><surname>Oltedal</surname><given-names>L.</given-names></name><name><surname>Davanger</surname><given-names>S.</given-names></name><name><surname>Hay</surname><given-names>J. C.</given-names></name></person-group> (<year>2004</year>) <source>J. Cell Sci.</source><volume>117</volume>, <fpage>4495</fpage>&#8211;<lpage>4508</lpage><pub-id pub-id-type="pmid">15331663</pub-id></mixed-citation></ref><ref id="B28"><label>28.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hasegawa</surname><given-names>H.</given-names></name><name><surname>Zinsser</surname><given-names>S.</given-names></name><name><surname>Rhee</surname><given-names>Y.</given-names></name><name><surname>Vik-Mo</surname><given-names>E. O.</given-names></name><name><surname>Davanger</surname><given-names>S.</given-names></name><name><surname>Hay</surname><given-names>J. C.</given-names></name></person-group> (<year>2003</year>) <source>Mol. Biol. Cell</source><volume>14</volume>, <fpage>698</fpage>&#8211;<lpage>720</lpage><pub-id pub-id-type="pmid">12589064</pub-id></mixed-citation></ref><ref id="B29"><label>29.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pylypenko</surname><given-names>O.</given-names></name><name><surname>Sch&#246;nichen</surname><given-names>A.</given-names></name><name><surname>Ludwig</surname><given-names>D.</given-names></name><name><surname>Ungermann</surname><given-names>C.</given-names></name><name><surname>Goody</surname><given-names>R. S.</given-names></name><name><surname>Rak</surname><given-names>A.</given-names></name><name><surname>Geyer</surname><given-names>M.</given-names></name></person-group> (<year>2008</year>) <source>J. Mol. Biol.</source><volume>377</volume>, <fpage>1334</fpage>&#8211;<lpage>1345</lpage><pub-id pub-id-type="pmid">18329045</pub-id></mixed-citation></ref><ref id="B30"><label>30.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wen</surname><given-names>W.</given-names></name><name><surname>Yu</surname><given-names>J.</given-names></name><name><surname>Pan</surname><given-names>L.</given-names></name><name><surname>Wei</surname><given-names>Z.</given-names></name><name><surname>Weng</surname><given-names>J.</given-names></name><name><surname>Wang</surname><given-names>W.</given-names></name><name><surname>Ong</surname><given-names>Y. S.</given-names></name><name><surname>Tran</surname><given-names>T. H.</given-names></name><name><surname>Hong</surname><given-names>W.</given-names></name><name><surname>Zhang</surname><given-names>M.</given-names></name></person-group> (<year>2010</year>) <source>Mol. Cell</source><volume>37</volume>, <fpage>383</fpage>&#8211;<lpage>395</lpage><pub-id pub-id-type="pmid">20159557</pub-id></mixed-citation></ref><ref id="B31"><label>31.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martinez-Arca</surname><given-names>S.</given-names></name><name><surname>Rudge</surname><given-names>R.</given-names></name><name><surname>Vacca</surname><given-names>M.</given-names></name><name><surname>Raposo</surname><given-names>G.</given-names></name><name><surname>Camonis</surname><given-names>J.</given-names></name><name><surname>Proux-Gillardeaux</surname><given-names>V.</given-names></name><name><surname>Daviet</surname><given-names>L.</given-names></name><name><surname>Formstecher</surname><given-names>E.</given-names></name><name><surname>Hamburger</surname><given-names>A.</given-names></name><name><surname>Filippini</surname><given-names>F.</given-names></name><name><surname>D'Esposito</surname><given-names>M.</given-names></name><name><surname>Galli</surname><given-names>T.</given-names></name></person-group> (<year>2003</year>) <source>Proc. Natl. Acad. Sci. U.S.A.</source><volume>100</volume>, <fpage>9011</fpage>&#8211;<lpage>9016</lpage><pub-id pub-id-type="pmid">12853575</pub-id></mixed-citation></ref><ref id="B32"><label>32.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pryor</surname><given-names>P. R.</given-names></name><name><surname>Jackson</surname><given-names>L.</given-names></name><name><surname>Gray</surname><given-names>S. R.</given-names></name><name><surname>Edeling</surname><given-names>M. A.</given-names></name><name><surname>Thompson</surname><given-names>A.</given-names></name><name><surname>Sanderson</surname><given-names>C. M.</given-names></name><name><surname>Evans</surname><given-names>P. R.</given-names></name><name><surname>Owen</surname><given-names>D. J.</given-names></name><name><surname>Luzio</surname><given-names>J. P.</given-names></name></person-group> (<year>2008</year>) <source>Cell</source><volume>134</volume>, <fpage>817</fpage>&#8211;<lpage>827</lpage><pub-id pub-id-type="pmid">18775314</pub-id></mixed-citation></ref><ref id="B33"><label>33.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chaineau</surname><given-names>M.</given-names></name><name><surname>Danglot</surname><given-names>L.</given-names></name><name><surname>Proux-Gillardeaux</surname><given-names>V.</given-names></name><name><surname>Galli</surname><given-names>T.</given-names></name></person-group> (<year>2008</year>) <source>J. Biol. Chem.</source><volume>283</volume>, <fpage>34365</fpage>&#8211;<lpage>34373</lpage><pub-id pub-id-type="pmid">18819912</pub-id></mixed-citation></ref><ref id="B34"><label>34.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wen</surname><given-names>W.</given-names></name><name><surname>Chen</surname><given-names>L.</given-names></name><name><surname>Wu</surname><given-names>H.</given-names></name><name><surname>Sun</surname><given-names>X.</given-names></name><name><surname>Zhang</surname><given-names>M.</given-names></name><name><surname>Banfield</surname><given-names>D. K.</given-names></name></person-group> (<year>2006</year>) <source>Mol. Biol. Cell</source><volume>17</volume>, <fpage>4282</fpage>&#8211;<lpage>4299</lpage><pub-id pub-id-type="pmid">16855025</pub-id></mixed-citation></ref><ref id="B35"><label>35.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martinez-Arca</surname><given-names>S.</given-names></name><name><surname>Alberts</surname><given-names>P.</given-names></name><name><surname>Zahraoui</surname><given-names>A.</given-names></name><name><surname>Louvard</surname><given-names>D.</given-names></name><name><surname>Galli</surname><given-names>T.</given-names></name></person-group> (<year>2000</year>) <source>J. Cell Biol.</source><volume>149</volume>, <fpage>889</fpage>&#8211;<lpage>900</lpage><pub-id pub-id-type="pmid">10811829</pub-id></mixed-citation></ref><ref id="B36"><label>36.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Braun</surname><given-names>V.</given-names></name><name><surname>Fraisier</surname><given-names>V.</given-names></name><name><surname>Raposo</surname><given-names>G.</given-names></name><name><surname>Hurbain</surname><given-names>I.</given-names></name><name><surname>Sibarita</surname><given-names>J. B.</given-names></name><name><surname>Chavrier</surname><given-names>P.</given-names></name><name><surname>Galli</surname><given-names>T.</given-names></name><name><surname>Niedergang</surname><given-names>F.</given-names></name></person-group> (<year>2004</year>) <source>EMBO J.</source><volume>23</volume>, <fpage>4166</fpage>&#8211;<lpage>4176</lpage><pub-id pub-id-type="pmid">15470500</pub-id></mixed-citation></ref><ref id="B37"><label>37.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>O.</given-names></name><name><surname>Kay</surname><given-names>L. E.</given-names></name><name><surname>Olivier</surname><given-names>J. P.</given-names></name><name><surname>Forman-Kay</surname><given-names>J. D.</given-names></name></person-group> (<year>1994</year>) <source>J. Biomol. NMR</source><volume>4</volume>, <fpage>845</fpage>&#8211;<lpage>858</lpage><pub-id pub-id-type="pmid">7812156</pub-id></mixed-citation></ref><ref id="B38"><label>38.</label><mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Goddard</surname><given-names>T. D.</given-names></name><name><surname>Kneller</surname><given-names>D. G.</given-names></name></person-group><source>SPARKY 3</source> (<year>2007</year>) <publisher-name>University of California</publisher-name>, <publisher-loc>San Francisco, CA</publisher-loc></mixed-citation></ref><ref id="B39"><label>39.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gonzalez</surname><given-names>L. C.</given-names><suffix>Jr.</suffix></name><name><surname>Weis</surname><given-names>W. I.</given-names></name><name><surname>Scheller</surname><given-names>R. H.</given-names></name></person-group> (<year>2001</year>) <source>J. Biol. Chem.</source><volume>276</volume>, <fpage>24203</fpage>&#8211;<lpage>24211</lpage><pub-id pub-id-type="pmid">11309394</pub-id></mixed-citation></ref></ref-list></back></article>